What is the appropriate management for a patient with a urine culture showing vancomycin‑resistant Enterococcus faecium (≈50 000 CFU) and low‑count gram‑negative bacilli (≈2‑3 × 10³ CFU)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Polymicrobial Urine Culture with VRE faecium

For this urine culture showing vancomycin-resistant Enterococcus faecium (VRE) at 50,000 CFU as the predominant pathogen with low-count gram-negative bacilli, treatment should target the VRE if the patient is symptomatic; if asymptomatic, no treatment is indicated as this likely represents colonization or asymptomatic bacteriuria.

Determining Need for Treatment

The critical first step is distinguishing true infection from colonization 1, 2:

  • Symptomatic UTI (dysuria, urgency, frequency, fever, flank pain, suprapubic pain) → Treat
  • Asymptomatic bacteriuria → Do NOT treat (this accounts for 64% of VRE-positive urine cultures) 2
  • The presence of VRE in urine does not automatically warrant antimicrobial therapy 1, 3

If Treatment is Indicated

For Uncomplicated UTI (Cystitis):

First-line oral options for VRE faecium 1:

  1. Linezolid 600 mg PO every 12 hours for 5-7 days (Strong recommendation) 1

    • This is the only reliable oral agent for VRE faecium 4
    • VRE faecium shows >90% susceptibility to linezolid 4
    • VRE faecium is typically <15% susceptible to ampicillin, ciprofloxacin, nitrofurantoin, and tetracycline 4
  2. Fosfomycin 3 g PO single dose or every other day (Weak recommendation) 1

    • Only 57% susceptibility rate for VRE faecium 4
    • Less reliable than linezolid

Do NOT use ampicillin or nitrofurantoin for VRE faecium—these have poor activity (<15% susceptibility) 4, 5

For Complicated UTI or Pyelonephritis:

Parenteral options 1:

  1. Linezolid 600 mg IV every 12 hours for 5-7 days (Strong recommendation)
  2. Daptomycin 6-12 mg/kg IV daily for 5-7 days (Weak recommendation) 1
    • Use higher doses (8-12 mg/kg) for serious infections 1, 6

Addressing the Gram-Negative Bacilli

The low colony counts (2,000-3,000 CFU) of gram-negative organisms are below the traditional 10,000-100,000 CFU threshold for clinical significance in most UTI contexts. These likely represent:

  • Contamination
  • Colonization
  • Polymicrobial colonization in a catheterized patient

Clinical approach:

  • If the patient has an indwelling catheter, remove it if possible 6, 3
  • The VRE at 50,000 CFU is the dominant organism and should guide therapy if treatment is needed
  • Gram-negative coverage is typically unnecessary unless the patient has severe sepsis, pyelonephritis, or structural urinary abnormalities 7

Critical Pitfalls to Avoid

  1. Treating asymptomatic bacteriuria: This is the most common error—most VRE-positive urine cultures do not require treatment 2, 3

  2. Using broad-spectrum agents unnecessarily: Despite 82% ampicillin susceptibility in VRE faecalis, VRE faecium is typically ampicillin-resistant 5

  3. Assuming all VRE are the same: VRE faecium and VRE faecalis have vastly different susceptibility patterns 4, 5

  4. Ignoring prior cultures: Check for previous urine cultures showing resistant organisms, as prior resistance strongly predicts current resistance 7

  5. Overlooking catheter removal: Patients with indwelling catheters often have colonization rather than infection 7, 6

Special Considerations

  • Patients with neurogenic bladders or chronic catheters are likely colonized with resistant organisms and should not be treated unless symptomatic 7
  • Linezolid has limited urinary excretion but remains effective for VRE UTI 2, 3
  • Duration: 5-7 days for uncomplicated UTI, individualized for complicated infections based on clinical response 1

Related Questions

Should an asymptomatic patient with an Enterococcus faecalis urine culture be treated with antibiotics?
For a vancomycin-resistant Enterococcus faecalis urinary tract infection that is susceptible to ampicillin, is oral amoxicillin an appropriate treatment?
In a patient with a urine culture growing 20–25,000 CFU/mL vancomycin‑resistant Enterococcus (VRE) but no symptoms of urinary tract infection, should antimicrobial therapy be initiated?
What antibiotic regimen is recommended for a stable, non‑septic patient with a urinary tract infection culture positive for Acinetobacter calcoaceticus and Enterococcus faecium, with a prior low‑colony Enterococcus faecium infection three months ago, and also positive for Clostridioides difficile PCR and enzyme immunoassay, who is currently on oral vancomycin?
How many days of therapy are recommended for a vancomycin-resistant Enterococcus urinary infection in an adult with normal renal function?
What is the recommended diagnostic work‑up and treatment plan for a patient with suspected alveolar echinococcosis presenting with hepatic cystic lesions after living or traveling in endemic regions such as western China, central Asia, the Alpine, sub‑Arctic or Arctic areas?
What is the etiology of alveolar echinococcosis?
What is the appropriate management for a 7-month-old infant with fecal impaction, and should digital removal be performed?
What are the clinical manifestations of alveolar echinococcosis?
What are the recent studies on pramipexole?
What quantitative serum TSH assay should be ordered when performing a stimulated thyroglobulin measurement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.